Our Neuropsychologists Dr. Laura Jansons, Dr. Skip Hrin , and Neurofeedback Tech legend Jay Gunkelman discuss Alzheimer's and the new Drug Aduhelm, which was recently fast-tracked by the FDA. They also discussed all the studies that show positive results for Neurofeedback that do not get the same publicity.

JG" Very disappointed in the FDA"

JG " The FDA has become politicized

JG If all the vendors could push in the same direction things could move somewhere"

Notes:

Brainfutures
Tomas Ros Video
You can't make up a Placebo
Why isn't Neurofeedback taught in Colleges
Martijn Arns

Have an idea for a topic or guest? pete@neuronoodle.com

Alzheimers, Aduhelm, FDA and Neurofeedback Studies